Author
@Pharmdca Pharmdca
grade Cx.com/Pharmdca ↗
Long-only dip-buying biotech-and-megacap-tech bull who discloses every entry
Posts real-time, ticker-specific add/trim/buy-the-dip disclo
trader score
+0.82
hit rate
60%
mean α
+0.36%
signals 14d
141
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 60% hit rate, +0.36% mean alpha, trader score +0.82. Their last-14d mentions, direction-adjusted, have moved -4.0% since posting (mean over 103 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-28 | · | @Pharmdca | · | States an expectation that no rate hike will occur before the midterm elections. | · | tweet ↗ |
| 2026-08-28 | CYTK | @Pharmdca | +0.70 | Added CYTK shares above $72. — Explicitly reports adding CYTK shares around $72 or higher. | — | tweet ↗ |
| 2026-08-28 | SPY | @Pharmdca | +0.00 | Flags September's FOMC decision as a major macro event for SPY without choosing hike or hold. | — | tweet ↗ |
| 2026-08-28 | IVVD | @Pharmdca | +0.65 | Frames upcoming biotech readouts as catalysts and calls IVVD a compelling high-risk lotto position. | · | tweet ↗ |
| 2026-08-28 | VKTX | @Pharmdca | +0.35 | Frames upcoming biotech readouts as catalysts and calls IVVD a compelling high-risk lotto position. | — | tweet ↗ |
| 2026-08-28 | META | @Pharmdca | +0.65 | Discloses AMZN and META as the author's largest positions. | — | tweet ↗ |
| 2026-08-28 | AMZN | @Pharmdca | +0.65 | Discloses AMZN and META as the author's largest positions. | — | tweet ↗ |
| 2026-08-28 | META | @Pharmdca | +0.55 | Expects meaningful upside from current levels in four named stocks. | — | tweet ↗ |
| 2026-08-28 | APP | @Pharmdca | +0.55 | Expects meaningful upside from current levels in four named stocks. | — | tweet ↗ |
| 2026-08-28 | AMZN | @Pharmdca | +0.55 | Expects meaningful upside from current levels in four named stocks. | — | tweet ↗ |
| 2026-08-28 | RDDT | @Pharmdca | +0.55 | Expects meaningful upside from current levels in four named stocks. | — | tweet ↗ |
| 2026-08-28 | APP | @Pharmdca | +0.60 | Expects APP and RDDT to move higher after their current consolidation. | — | tweet ↗ |
| 2026-08-28 | RDDT | @Pharmdca | +0.60 | Expects APP and RDDT to move higher after their current consolidation. | — | tweet ↗ |
| 2026-08-28 | RBRK | @Pharmdca | +0.45 | Looks back on a software panic selloff as an opportunity for traders who acted. | — | tweet ↗ |
| 2026-08-28 | NOW | @Pharmdca | +0.45 | Looks back on a software panic selloff as an opportunity for traders who acted. | — | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.